Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sanofi S.A. | 4 | 0 | 0 | 0 | €104.32 | €109.00 | 4.486% |
| Laboratory Corp. Of America (labcorp) | 15 | 0 | 0 | 0 | €197.00 | €239.41 | 21.527% |
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €208.40 | €224.50 | 7.726% |
| Dentsply Sirona Inc. | 17 | 0 | 1 | 0 | €23.06 | €35.04 | 51.951% |
| bioMerieux S.A. | 1 | 0 | 1 | 0 | €105.10 | - | - |
| Johnson & Johnson | 39 | 1 | 1 | 0 | €148.28 | €194.53 | 31.192% |
| Teva Pharmaceutical Industries Ltd ADR | 20 | 0 | 1 | 0 | €16.35 | €19.35 | 18.377% |
| Humana Inc. | 24 | 0 | 1 | 0 | €322.80 | €381.08 | 18.053% |
| Gilead Sciences Inc | 11 | 0 | 1 | 0 | €71.02 | €85.74 | 20.722% |
| Merck KGaA | 5 | 1 | 1 | 0 | €168.35 | €172.00 | 2.168% |
| Hologic Inc. | 19 | 0 | 1 | 0 | €74.00 | €83.38 | 12.670% |
| Merck & Co. Inc. | 31 | 1 | 1 | 0 | €106.40 | €125.78 | 18.214% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Edwards Lifesciences Corp. | 32 | 1 | 1 | 0 | €60.29 | €83.40 | 38.339% |
| Stryker Corp. | 31 | 0 | 2 | 0 | €323.90 | €340.93 | 5.257% |
| Sanofi S.A. ADR | 7 | 0 | 2 | 0 | €52.50 | €55.25 | 5.246% |
| UnitedHealth Group Inc. | 43 | 1 | 2 | 0 | €538.80 | €548.28 | 1.759% |
| Dexcom Inc. | 26 | 0 | 2 | 0 | €61.88 | €121.12 | 95.739% |
| Abbott Laboratories | 20 | 0 | 2 | 0 | €102.78 | €116.25 | 13.103% |
| Cigna Corp. | 24 | 0 | 2 | 0 | €318.95 | €360.98 | 13.177% |
| Universal Health Services B | 15 | 6 | 2 | 0 | €208.00 | €190.70 | -8.318% |
| AbbVie Inc. | 34 | 0 | 2 | 0 | €174.48 | €180.90 | 3.681% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €170.66 | €196.17 | 14.946% |
| Agilent Technologies Inc. | 16 | 5 | 3 | 1 | €123.74 | €134.50 | 8.697% |
| Boston Scientific | 56 | 0 | 3 | 0 | €74.00 | €78.23 | 5.722% |